1 Seizure freedom |
4 |
361 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.51 [0.93, 2.43] |
2 50% or greater reduction in seizure frequency |
5 |
401 |
Risk Ratio (M‐H, Random, 95% CI) |
1.42 [1.07, 1.89] |
3 Post‐treatment quality of life score (QOLIE‐31 score) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
4 Frequency of adverse effects |
1 |
|
Risk Ratio (M‐H, Fixed, 99% CI) |
Totals not selected |
4.1 Dizziness |
1 |
|
Risk Ratio (M‐H, Fixed, 99% CI) |
0.0 [0.0, 0.0] |
4.2 Malaise |
1 |
|
Risk Ratio (M‐H, Fixed, 99% CI) |
0.0 [0.0, 0.0] |
4.3 Nausea |
1 |
|
Risk Ratio (M‐H, Fixed, 99% CI) |
0.0 [0.0, 0.0] |
4.4 Anorexia |
1 |
|
Risk Ratio (M‐H, Fixed, 99% CI) |
0.0 [0.0, 0.0] |
4.5 Impaired concentration |
1 |
|
Risk Ratio (M‐H, Fixed, 99% CI) |
0.0 [0.0, 0.0] |
5 75% or greater reduction in seizure frequency |
5 |
401 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.48 [1.22, 1.79] |
6 25% or greater reduction in seizure frequency |
5 |
401 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.09 [1.03, 1.16] |
7 Post‐treatment seizure frequency |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
8 Post‐treatment epilepsy score |
2 |
180 |
Mean Difference (IV, Random, 95% CI) |
‐1.56 [‐3.69, 0.57] |
9 70% or greater reduction in epilepsy score |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
10 40% or greater reduction in epilepsy score |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
11 20% or greater reduction in epilepsy score |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
12 Post‐treatment Global Clinical Impression (GCI) score |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
12.1 Severity Index |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
12.2 Global Improvement |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
12.3 Efficacy Index |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
13 Post‐treatment EEG abnormality |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
13.1 Severe abnormality |
2 |
249 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.83 [0.43, 1.60] |
13.2 Moderate abnormality |
2 |
249 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.75 [0.53, 1.05] |
13.3 Mild abnormality |
2 |
249 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.29 [0.91, 1.84] |
13.4 Borderline abnormality |
1 |
120 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.8 [0.23, 2.83] |